U.K. Home Healthcare Market Segments, Size, Covid-19 Impact, Insights Forecast to 2026

A Story by nita

The global u.k. home healthcare market is expected to rise with an impressive CAGR and generate the highest revenue by 2026. Fortune Business Insights™ in its latest report published this information. The report is titled "U.K. Home Healthcare Market, Share and Global Trend Product By Product(Continence Careand,Ostomy Care, Clinical Nutrition, Respiratory Care, Equipments & Housekeeping Supplies, Disposables) and geography forecast 2026". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

View press release for more information @ https://www.fortunebusinessinsights.com/industry-reports/u-k-home-healthcare-market-100866

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other u.k. home healthcare market trends. The report is available for sale on the company website.

Medtronic Receives FDA Approval for its Second Cement Solution to Treat Sacral Fractures

The report profiles some of the leading players in the global kyphoplasty market. Some of them are

Medtronic
Stryker
Merit Medical Systems
DePuy Synthes (Johnson & Johnson Services Inc.),
Alphatec Spine Inc.
G21 Srl, Taeyeon Medical Co. Ltd.
Joline GmbH & Co. KG
iMEDICOM
RONTIS

These companies have an expansive orthopaedic portfolio and robust distribution network. This allows them to sell their products effectively, which in turn, affects the kyphoplasty market revenue. SAFE ORTHOPEDICS announced the launch of a new kyphoplasty system called The SteriSpine VA in October 2018. This system holds a new cement injection method, which uses balloon for the treatment of fractures. In June 2018, Medtronic announced its second bone cement solution. This solution is for fixing pathological fractures of sacral vertebral body with the help of sacroplasty. The company received FDA approval for this solution called Kyphos(TM) Xpede Bone Cement.

Adoption of Kyphoplasty Devices Can Reduce the Overall Healthcare Expenditure

A lead analyst at Fortune Business Insights said, “Not only osteoporosis but the rising prevalence of osteopenia especially in elderly population is driving the market.” He added,” The rising aging population across the world is bringing unique health-related issues to the forefront of medicine, thus giving rise to kyphoplasty.” Kyphoplasty helps to improve the mobility in patients and allows them to perform daily tasks. The rising demand for outpatients is contributing to the growth of the market. Kyphoplasty devices can help an outpatient to treat fractures within an hour. This further helps to minimize the overall healthcare cost.

Regional Analysis for U.K. Home Healthcare Market:

North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Major Table of Contents for U.K. Home Healthcare Market: